Exclusive: NICE to routinely review drugs' budget impact for NHS England

pills

The National Institute for Health and Care Excellence has been asked to routinely assess the financial impact of specialised commissioning treatments for NHS England, a document seen by HSJ reveals.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here